The 52-Week Low Club

As the market moves higher almost everyday, the membership in the Club becomes more exclusive.

NeuroChem (NMRX) Negative news about phase 3 clinical trial data for its Alzheimer's drug candidate, Alzhemed, followed by an $80 million in convertible notes. Brutal day for the shareholder. Down 22% to $9.06, and moving further off the 52-week high of $26.91.

Harris Stratex Networks (HSTX) Wireless transmissions systems supplier is another 20% decliner today on poor earnings outlook. Falls to $14.85 down from 52-week high of $21.25.

AudioCodecs (AUDC) Joins the club again. Downgrade from Piper Jaffray after Q1 loss. Drops to $5.86 from 52-week high of $14.00.

Power-One (PWER) Wall Street Journal said management sold shares before bad news. Big loss from operations in last quarter from designer and manufacturer of power conversion products. Drops to $4.02 from 52-week high of $8.15.

Douglas A. McIntyre